Venmax Drugs And Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Secunderabad, Telangana, India, established in 1988.
1988 Secunderabad, Telangana, India Active
Last Updated:
Access Report
About Venmax Drugs And Pharmaceuticals Limited

Venmax Drugs And Pharmaceuticals Limited, a active public limited company, was established on 28 September 1988 in Secunderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: L24230TG1988PLC009102. Registered under ROC Roc Hyderabad. it is listed on BSE: 531015. It has an authorized capital of ₹22.00 Cr and a paid-up capital of ₹8.78 Cr.

It upholds a active non-compliant status. In 2016, it reported revenue of ₹1.93 Cr and a net worth of ₹1.99 M. Its leadership includes Swapneswar Mishra (Director), Dasi Reddy Rakesh (Director), Gundluru Reddeppa (Director). Past directors included Nitesh Vijayvargiya, Nooka Krishnaiah, Gajula Gopal. It holds no open charges and ₹6.50 Cr settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sy. No. 115, Brig Sayeed Road, Hanumanji Colony, Bowenpally, Secunderabad, Telangana, 500009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24230TG1988PLC009102

  • Registration Number

    009102

  • Incorporation Date

    28 September 1988

  • Authorized Capital

    ₹22.00 Cr

  • Paid-Up Capital

    ₹8.78 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Listed (BSE: 531015)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 22.00 Cr
  • Paid Up Capital ₹ 8.78 Cr
  • Company Age 37 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 6.50 Cr
  • Revenue Growth **** -20.42%
  • Profit Growth **** -72.51%
  • Ebitda **** -20.43%
  • Net Worth -40.95%
  • Total Assets -29.55%
Company report

Venmax Drugs And Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Venmax Drugs And Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Venmax Drugs And Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Swapneswar Mishra Director 16 Jan 2024 Current
Dasi Reddy Rakesh Director 22 Aug 2024 Current
Gundluru Reddeppa Director 22 Aug 2024 Current
Sadhanala Venkata Rao Whole-Time Director 01 Oct 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Mar 2010 Past
Pramod Abcsdd Additional Director 30 Sep 2015 Past
Pramod Abcsdd Director 31 May 2012 Past
Pramod Abcsdd Additional Director 20 Sep 2024 Past
Pramod Abcsdd Director 03 Dec 2011 Past
Pramod Abcsdd Additional Director 20 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Venmax Drugs And Pharmaceuticals.

Venmax Drugs And Pharmaceuticals Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 20.42% decrease. The company also saw a substantial fall in profitability, with a 72.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.95%.

Venmax Drugs And Pharmaceuticals revenue growth over time
Venmax Drugs And Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -20.42%
*******
*******
*******
*******
Revenue from Operations
*******
 -20.42%
*******
*******
*******
*******
Total Assets
*******
 -29.55%
*******
*******
*******
*******
Profit or Loss
*******
 -72.51%
*******
*******
*******
*******
Net Worth
*******
 -40.95%
*******
*******
*******
*******
EBITDA
*******
 -20.43%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Venmax Drugs And Pharmaceuticals?

In 2017, Venmax Drugs And Pharmaceuticals had a promoter holding of 23.13% and a public holding of 76.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹65,020,000.00

Charges Breakdown by Lending Institutions
  • A.P. State Financial Corporation : 3.24 Cr
  • Union Bank Of India : 1.50 Cr
  • State Bank Of India : 1.06 Cr
  • A.P. Industrial Development Corporation Ltd. : 0.70 Cr
Latest Charge Details
Date Lender Amount Status
11 Jul 2008 Union Bank Of India ₹1.50 Cr Satisfied
17 Aug 1999 A.P. State Financial Corporation ₹1.43 Cr Satisfied
02 Aug 1999 A.P. Industrial Development Corporation Ltd. ₹7.00 M Satisfied
20 Aug 1991 A.P. State Financial Corporation ₹5.60 M Satisfied
13 Aug 1991 A.P. State Financial Corporation ₹0.62 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Venmax Drugs And Pharmaceuticals?

Venmax Drugs And Pharmaceuticals has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Venmax Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venmax Drugs And Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Venmax Drugs And Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Venmax Drugs And Pharmaceuticals Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Progress on Priyanka Agarwal was appointed as a Company Secretary was appointed as a Company Secretary on 02 May 2025 & has been associated with this company since 10 months 26 days . was documented.

  • Balance Sheet

    Venmax Drugs And Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    Sadhanala Venkata Rao was appointed as a Whole-time director was appointed as a Whole-time director on 01 Oct 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.

  • Director Appointment

    Sai Baba Kummarikuntla was appointed as a Cfo was appointed as a Cfo on 03 Sep 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.

  • Director Appointment

    Progress on Dasi Reddy Rakesh was appointed as a Director was appointed as a Director on 22 Aug 2024 & has been associated with this company since 1 year 7 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Venmax Drugs And Pharmaceuticals Limited?

The CIN of Venmax Drugs And Pharmaceuticals Limited is L24230TG1988PLC009102.

Where is Venmax Drugs And Pharmaceuticals Limited headquartered?

Venmax Drugs And Pharmaceuticals Limited is headquartered at Sy. No. 115, Brig Sayeed Road, Hanumanji Colony, Bowenpally, Secunderabad, Telangana, 500009.

When was Venmax Drugs And Pharmaceuticals Limited incorporated?

Venmax Drugs And Pharmaceuticals Limited was incorporated on 28 September 1988.

Who are the current directors of Venmax Drugs And Pharmaceuticals Limited?

The current directors of Venmax Drugs And Pharmaceuticals Limited are

What is the primary industry of Venmax Drugs And Pharmaceuticals Limited?

The primary industry of Venmax Drugs And Pharmaceuticals Limited is Pharma.

Is Venmax Drugs And Pharmaceuticals Limited a listed company?

Venmax Drugs And Pharmaceuticals Limited is listed. It is listed on BSE: 531015.

What is the capital structure of Venmax Drugs And Pharmaceuticals Limited?

The authorized capital of Venmax Drugs And Pharmaceuticals Limited is ₹22.00 Cr, and the paid-up capital is ₹8.78 Cr.

What is the compliance status of Venmax Drugs And Pharmaceuticals Limited?

The compliance status of Venmax Drugs And Pharmaceuticals Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available